All News #Library
Biotech
AceLink Announces Publication of Phase 1 Trial Data Evaluating AL01211
26 Feb 2024 //
BUSINESSWIRE
AceLink Announces First Patient Dosed in Phase 2 Trial of AL01211
31 Oct 2023 //
BUSINESSWIRE
AceLink Presents Preclinical Data on AL00804 at WORLD Symposium
23 Feb 2023 //
BUSINESSWIRE
AceLink Presents PI Study of AL01211 to Treat Fabry Disease at WORLD Symposium
23 Feb 2023 //
BUSINESSWIRE

Market Place
Sourcing Support